Pasar al contenido principal

A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms

Abierta
  • Código protocolo: 42847922MDD3003
  • Código EudraCT: No aplica
  • Servicio: Sin clasificar
  • Investigador/a principal:  Rodriguez Lopez, Amanda
  • Patología: Trastorns mentals i del comportament
  • Fase: Fase III